Genetic

Lilly Acquires Hearing Loss Specialist Akouos

Lilly has agreed to acquire Akouos, a precision genetic medicine company that is developing gene therapy treatments for hearing loss. Both companies’ boards have approved the deal, which is expected to close in the fourth quarter and cost Lilly up to $610 million.

News

Dow to Restrict GM Corn, Soybeans Sales Pending Chinese OK

Top-Feature

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Sasol

Leading Transformation

Dow Chemical Company

Anchored in Sustainability

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Easyfairs Deutschland GmbH

Leading the way. Driving results.

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Bayer AG

SchüllerConsulting